HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23 | +360.0% | 33,791 | +399.7% | 0.00% | – |
Q1 2023 | $5 | +25.0% | 6,762 | +9.7% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 6,162 | -57.3% | 0.00% | – |
Q3 2022 | $14,000 | -50.0% | 14,426 | 0.0% | 0.00% | – |
Q2 2022 | $28,000 | -68.2% | 14,426 | -17.4% | 0.00% | – |
Q1 2022 | $88,000 | -84.3% | 17,465 | -76.5% | 0.00% | – |
Q4 2021 | $562,000 | +128.5% | 74,262 | +138.3% | 0.00% | – |
Q3 2021 | $246,000 | -50.8% | 31,167 | -13.7% | 0.00% | – |
Q2 2021 | $500,000 | +39.7% | 36,105 | +111.3% | 0.00% | – |
Q1 2021 | $358,000 | +29.2% | 17,088 | +2.2% | 0.00% | – |
Q4 2020 | $277,000 | +9.9% | 16,716 | +12.8% | 0.00% | – |
Q3 2020 | $252,000 | -34.2% | 14,823 | -35.8% | 0.00% | – |
Q2 2020 | $383,000 | +133.5% | 23,101 | +62.6% | 0.00% | – |
Q1 2020 | $164,000 | -8.9% | 14,209 | +16.3% | 0.00% | – |
Q4 2019 | $180,000 | +102.2% | 12,220 | +87.2% | 0.00% | – |
Q3 2019 | $89,000 | +78.0% | 6,529 | +70.7% | 0.00% | – |
Q2 2019 | $50,000 | +614.3% | 3,824 | +403.2% | 0.00% | – |
Q1 2019 | $7,000 | – | 760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,105,000 | 22.35% |
MPM BioImpact LLC | 3,898,422 | $64,714,000 | 17.21% |
New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,495,000 | 13.92% |
Avidity Partners Management LP | 1,206,351 | $20,025,000 | 1.28% |
Consonance Capital Management LP | 844,162 | $14,013,000 | 0.84% |
Orbimed Advisors | 1,835,704 | $30,473,000 | 0.43% |
Artal Group S.A. | 900,000 | $14,940,000 | 0.42% |
Cormorant Asset Management, LP | 645,257 | $10,711,000 | 0.41% |
DAFNA Capital Management LLC | 85,119 | $1,413,000 | 0.41% |
Soleus Capital Management, L.P. | 30,886 | $512,000 | 0.29% |